October 01, 2020
Article
The FDA has approved golimumab for the treatment of patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis.
September 29, 2020
Inflammation caused by rheumatoid arthritis may increase the risk of type 2 diabetes.
The FDA has approved tofacitinib for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis.
September 23, 2020
A recent study found that patients on immunosuppressive therapy for common skin and rheumatic diseases, such as psoriasis and rheumatoid arthritis, are not at an increased risk for contracting COVID-19.
September 22, 2020
Recent studies have analyzed how individuals with autoimmune conditions prescribed specialty medications may be affected by the COVID-19 pandemic.
September 15, 2020
The Mediterranean diet has shown efficacy in preventing several noncommunicable diseases.
August 28, 2020
The new studies found that for some patients, the use of steroid medications to reduce inflammation slighly increased the likelihood of needing hospital care for COVID-19.
August 18, 2020
Extended glucocorticoid use can cause complications such as cardiovascular disorders, infections, and osteoporosis, according to a new study.
June 04, 2020
What characteristics of RA treatments possibly connect to COVID-19 treatment?
March 31, 2020
The American College of Rheumatology addresses the prior authorization requirement for some prescription medications, highlighting the significant burden this creates for patients and rheumatology professionals.
